Inventor · disambiguated record
Roland Burli
Also filed as: BUERLI ROLAND · BUERLI ROLAND W · BURLI ROLAND · BURLI ROLAND W
60 granted patents·18 pending applications·595 citations·filing 2001–2024
98Inventor score
Files withGENESOFT PHARMACEUTICALS INC14CHDI FOUNDATION INC10AMGEN INC9USHER III INITIATIVE INC7ASTRAZENECA AB6
Top patents by PatentIndex Score
78 records- 0197US7348427B2Antipathogenic benzamide compoundsGENESOFT PHARMACEUTICALS INC·Filed 2004·Granted Mar 25, 2008·87 cites·5 claims
- 0296US7329765B2Benzothiophene compounds having antiinfective activityGENESOFT PHARMACEUTICALS INC·Filed 2004·Granted Feb 12, 2008·88 cites·16 claims
- 0395US6777425B2Isoquinoline compounds having antiinfective activityGENESOFT PHARMACEUTICALS INC·Filed 2002·Granted Aug 17, 2004·132 cites·23 claims
- 0494US6555693B2Charged compounds comprising a nucleic acid binding moiety and uses thereforGENESOFT INC·Filed 2001·Granted Apr 29, 2003·81 cites·12 claims
- 0592US11434236B2Halo-substituted piperidines as orexin receptor modulatorsASTRAZENECA AB·Filed 2020·Granted Sep 6, 2022·2 cites·32 claims
- 0691US9079909B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher SyndromeUSHER III INITIATIVE·Filed 2013·Granted Jul 14, 2015·8 cites·14 claims
- 0791US8765762B2Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE·Filed 2013·Granted Jul 1, 2014·11 cites·18 claims
- 0891US8399483B2Quinoxaline and quinoline derivatives as kinase inhibitorsALLEN DANIEL REES·Filed 2008·Granted Mar 19, 2013·51 cites·12 claims
- 0990US9549910B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2015·Granted Jan 24, 2017·3 cites·2 claims
- 1090US9260381B2Pyrazolopyridazines and methods for treating retinal degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2015·Granted Feb 16, 2016·4 cites·2 claims
- 1190US9227976B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2013·Granted Jan 5, 2016·6 cites·38 claims
- 1288US7919519B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2007·Granted Apr 5, 2011·14 cites·8 claims
- 1387US9783545B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2016·Granted Oct 10, 2017·3 cites·16 claims
- 1487US9371332B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndromeUSHER III INITIATIVE INC·Filed 2015·Granted Jun 21, 2016·4 cites·2 claims
- 1587US7635715B2Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereofAMGEN INC·Filed 2007·Granted Dec 22, 2009·7 cites·50 claims
- 1685US10307422B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2018·Granted Jun 4, 2019·1 cites·2 claims
- 1784US10894789B2Halo-substituted piperidines as orexin receptor modulatorsASTRAZENECA AB·Filed 2017·Granted Jan 19, 2021·2 cites·30 claims
- 1882US9925187B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2016·Granted Mar 27, 2018·1 cites·3 claims
- 1982US9617259B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2014·Granted Apr 11, 2017·3 cites·39 claims
- 2082US2024400550A1Halo-substituted piperidines as orexin receptor modulatorsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 2181US11065336B2Conjugates for targeting and clearing aggregatesMEDIMMUNE LTD·Filed 2019·Granted Jul 20, 2021·4 cites·12 claims
- 2281US6825228B2Benzothiophene compounds having antiinfective activityGENESOFT PHARMACEUTICALS INC·Filed 2002·Granted Nov 30, 2004·14 cites·14 claims
- 2380US12084437B2Halo-substituted piperidines as orexin receptor modulatorsASTRAZENECA AB·Filed 2022·Granted Sep 10, 2024·0 cites·4 claims
- 2480US6716866B2Aryl-benzimidazole compounds having antiinfective activityGENESOFT PHARMACEUTICALS INC·Filed 2002·Granted Apr 6, 2004·10 cites·42 claims
- 2579US7301037B2Charged compounds comprising a nucleic acid binding moiety and uses thereforGENESOFT INC·Filed 2006·Granted Nov 27, 2007·1 cites·11 claims
- 2679US7078536B2Charged compounds comprising a nucleic acid binding moiety and uses thereforGENESOFT PHARMACEUTICALS INC·Filed 2002·Granted Jul 18, 2006·19 cites·12 claims
- 2778US9505736B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2013·Granted Nov 29, 2016·3 cites·21 claims
- 2877US10550089B2Inhibitors of protease-activated receptor-2HEPTARES THERAPEUTICS LTD·Filed 2017·Granted Feb 4, 2020·1 cites·7 claims
- 2977US8012968B2Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereofAMGEN INC·Filed 2010·Granted Sep 6, 2011·4 cites·15 claims
- 3076US9562021B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2014·Granted Feb 7, 2017·3 cites·16 claims
- 3176US8048894B2Quinolones and azaquinolones that inhibit prolyl hydroxylaseAMGEN INC·Filed 2008·Granted Nov 1, 2011·2 cites·23 claims
- 3276US7728130B2Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activityAMGEN INC·Filed 2006·Granted Jun 1, 2010·2 cites·6 claims
- 3375US8030346B2Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activityAMGEN INC·Filed 2008·Granted Oct 4, 2011·2 cites·74 claims
- 3474US10106535B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2017·Granted Oct 23, 2018·1 cites·18 claims
- 3573US10457675B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2018·Granted Oct 29, 2019·1 cites·20 claims
- 3673US7569726B2Indanone derivatives that inhibit prolyl hydroxylaseAMGEN INC·Filed 2008·Granted Aug 4, 2009·1 cites·23 claims
- 3772US7642245B2Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motifOSCIENT PHARMACEUTICALS CORP·Filed 2006·Granted Jan 5, 2010·1 cites·1 claims
- 3872US7498405B2Halogen-substituted thienyl compoundsGENESOFT PHARMACEUTICALS INC·Filed 2006·Granted Mar 3, 2009·1 cites·12 claims
- 3971US9783488B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2014·Granted Oct 10, 2017·1 cites·43 claims
- 4071US8097620B2Diazaquinolones that inhibit prolyl hydroxylase activityALLEN JENNIFER R·Filed 2008·Granted Jan 17, 2012·1 cites·62 claims
- 4171US8080542B2S1P receptor modulating compounds and use thereofNEIRA SUSANA C·Filed 2008·Granted Dec 20, 2011·2 cites·8 claims
- 4269US8349868B2Azaquinolones that inhibit prolyl hydroxylaseAMGEN INC·Filed 2011·Granted Jan 8, 2013·1 cites·25 claims
- 4369US7498349B2Biaryl compounds having anti-infective activityGENESOFT PHARMACEUTICALS INC·Filed 2003·Granted Mar 3, 2009·4 cites·13 claims
- 4468US10065948B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2015·Granted Sep 4, 2018·1 cites·51 claims
- 4568US8017626B2Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereofAMGEN INC·Filed 2010·Granted Sep 13, 2011·1 cites·16 claims
- 4666US12076406B2Conjugates for targeting and clearing aggregatesMEDIMMUNE LTD·Filed 2021·Granted Sep 3, 2024·0 cites·24 claims
- 4766US7129214B2Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motifOSCIENT PHARMACEUTICALS CORP·Filed 2003·Granted Oct 31, 2006·3 cites·10 claims
- 4866US2011178074A1Antipathogenic benzamide compoundsGENESOFT PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4966US2008200465A1Antipathogenic benzamide compoundsGENESOFT PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 5065US10995072B2Inhibitors of protease-activated receptor-2HEPTARES THERAPEUTICS LTD·Filed 2019·Granted May 4, 2021·0 cites·13 claims
Showing the top 50 of 78 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →